Table 2 Outcomes measure of included studies
Study,year | PET/MR | PET/CT | ||||||
|---|---|---|---|---|---|---|---|---|
TP | TN | FP | FN | TP | TN | FP | FN | |
Ohno Y [2], 2015 | 115 | 13 | 3 | 9 | 115 | 12 | 4 | 9 |
Heusch P [3], 2015 | 4 | 30 | 3 | 5 | 4 | 27 | 6 | 5 |
Lee SM [4], 2016 | 5 | 39 | 0 | 1 | 4 | 39 | 0 | 2 |
Melsaether AN [5], 2016 | 30 | 18 | 3 | 0 | 28 | 17 | 5 | 1 |
Huellner MW [6], 2016 | 11 | 26 | 4 | 1 | 12 | 28 | 2 | 0 |
Sekine T [7], 2017 | 11 | 31 | 1 | 0 | 9 | 32 | 0 | 2 |
Catalano OA [8] 2017 | 20 | 30 | 0 | 1 | 17 | 29 | 2 | 3 |
Ohno Y [9] 2017 | 4 | 60 | 0 | 0 | 2 | 60 | 0 | 2 |
Botsikas D [10] 2019 | 11 | 65 | 2 | 2 | 9 | 67 | 0 | 4 |
Ohno Y [11] 2019 | 2 | 20 | 0 | 1 | 3 | 19 | 1 | 0 |
Liu Y [12] 2019 | 3 | 22 | 0 | 1 | 3 | 22 | 0 | 1 |
Yeh CH [13] 2020 | 38 | 137 | 6 | 17 | 36 | 133 | 10 | 19 |
Ohno Y [14] 2020 | 11 | 90 | 1 | 2 | 11 | 89 | 2 | 2 |
Ohno Y [15] 2021 | 16 | 71 | 6 | 5 | 21 | 67 | 2 | 8 |